Gritstone bio, Inc.
GRTS · NASDAQ
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $2 |
| % Growth | 16.3% | 69% | -98.1% | – |
| Cost of Goods Sold | $2 | $2 | $2 | $2 |
| Gross Profit | -$2 | -$2 | -$2 | -$0 |
| % Margin | -2,707% | -3,455.1% | -6,524.1% | -25.5% |
| R&D Expenses | $21 | $33 | $33 | $33 |
| G&A Expenses | $8 | $9 | $8 | $7 |
| SG&A Expenses | $6 | $7 | $6 | $7 |
| Sales & Mktg Exp. | -$2 | -$2 | -$2 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | -$0 |
| Operating Expenses | $27 | $40 | $39 | $40 |
| Operating Income | -$28 | -$41 | -$41 | -$39 |
| % Margin | -49,915.8% | -84,681.6% | -140,775.9% | -2,466.7% |
| Other Income/Exp. Net | $4 | -$1 | -$0 | $0 |
| Pre-Tax Income | -$23 | -$40 | -$31 | -$38 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$23 | -$40 | -$31 | -$38 |
| % Margin | -41,045.6% | -82,418.4% | -106,269% | -2,455.8% |
| EPS | -0.16 | -0.34 | -0.32 | -0.33 |
| % Growth | 52.9% | -6.3% | 3% | – |
| EPS Diluted | -0.16 | -0.34 | -0.32 | -0.33 |
| Weighted Avg Shares Out | 143 | 118 | 98 | 115 |
| Weighted Avg Shares Out Dil | 143 | 118 | 98 | 115 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $1 | $1 |
| Interest Expense | $1 | $1 | $1 | $1 |
| Depreciation & Amortization | $2 | $2 | $2 | $2 |
| EBITDA | -$20 | -$37 | -$28 | -$35 |
| % Margin | -35,950.9% | -76,218.4% | -95,444.8% | -2,267% |